Jump to content

Scott Gottlieb

From Simple English Wikipedia, the free encyclopedia
Scott Gottlieb
Commissioner of the Food and Drug Administration
In office
May 11, 2017 – April 5, 2019[1]
PresidentDonald Trump
Preceded byRobert Califf
Succeeded byStephen Hahn
Deputy Commissioner of Food and Drugs
In office
PresidentGeorge W. Bush
Personal details
EducationWesleyan University
Mount Sinai School of Medicine

Scott Gottlieb is an American physician. Gottlieb was commissioner of the Food and Drug Administration from 2017 to 2019.[2][3][4][5]

Gottlieb was a clinical assistant professor at New York University School of Medicine, a resident fellow at the conservative think tank the American Enterprise Institute, and an internist at Tisch Hospital.[6]

References[change | change source]

  1. McGinley, Laurie; Bernstein, Lenny (March 5, 2019). "FDA Commissioner Gottlieb, who raised alarms about teen vaping, resigns". Washington Post. Retrieved March 5, 2019.
  2. LaMotte, Sandee (April 4, 2017). "Scott Gottlieb: Conflicts surround Trump's FDA pick". CNN. Retrieved 3 May 2017.
  3. Neel, Joe (March 10, 2017). "Trump To Nominate Dr. Scott Gottlieb To Head Food And Drug Administration". NPR. Retrieved March 10, 2017.
  4. Thomas, Katie, "F.D.A. Official Under Bush Is Said to Be Trump’s Choice to Lead Agency", New York Times, March 10, 2017. Retrieved 2017-03-10.
  5. Cunningham, Paige Winfield, "Trump expected to pick Scott Gottlieb to head FDA", Washington Examiner, March 10, 2017. Retrieved 2017-03-10.
  6. Dalzell, Michael D. (2011). "A Conversation With Scott Gottlieb, MD: The impact of health care reform on access to biologics, health policy, and managed care". Biotechnology Healthcare. 8 (3): 19–22. PMC 3278114. PMID 22479219.